| Literature DB >> 25928772 |
Marvin E Belzer1, Karen Kolmodin MacDonell2, Leslie F Clark1, Jennifer Huang3, Johanna Olson1, Shoshana Y Kahana4, Sylvie Naar2, Moussa Sarr3, Sarah Thornton3.
Abstract
A pilot randomized clinical trial of youth ages 15-24 nonadherent to antiretroviral therapy (ART) utilizing daily cell phone support was found to have significant improvement in self-reported adherence and HIV RNA. Understanding acceptability and feasibility is critical for future implementation in clinic settings. Exit interviews were obtained from participants and adherence facilitators (AF). Acceptability was assessed from content analysis of exit interviews. Feasibility was assessed via intervention retention and study retention rates. Thirty-seven eligible youth were enrolled with 19 assigned to the intervention. Seven (37%) discontinued the intervention either due to missing over 20% of calls for two consecutive months (N=5) or missing 10 consecutive calls (N=2). Sixteen participants completed exit interviews, 15 reported the call length was just right, 13 reported they would have liked to continue calls after the 24-week intervention, and all participants reported they would recommend the intervention to friends. Scheduling and making calls required less than 1 h per week per participant. Providing cell phone support to youth nonadherent to ART was acceptable and feasible. While the cost is low compared to the price of ART, healthcare systems will need to explore how to cover the cost of providing cell phones (incentive).Entities:
Mesh:
Substances:
Year: 2015 PMID: 25928772 PMCID: PMC4516960 DOI: 10.1089/apc.2014.0282
Source DB: PubMed Journal: AIDS Patient Care STDS ISSN: 1087-2914 Impact factor: 5.078